Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies.

IF 42.1 1区医学 Q1 ONCOLOGY

Journal of Clinical Oncology Pub Date : 2024-11-10 Epub Date: 2024-09-17 DOI:10.1200/JCO-24-01200

Jaleh Fallah, Flora Mulkey, Mallorie H Fiero, Haley Gittleman, Chi Song, Jeevan Puthiamadathil, Anup Amatya, Sundeep Agrawal, Paz Vellanki, Daniel L Suzman, Harpreet Singh, Laleh Amiri-Kordestani, Pallavi Mishra-Kalyani, Richard Pazdur, Paul G Kluetz

引用次数: 0

Abstract

FDA Oncology Center's @Falleh_Fallah and colleagues discuss loss of equipoise and other trial conduct challenges in an era of breakthrough therapies - via @JCO_ASCO.

查看原文本刊更多论文

Equipoise Lost?突破性疗法时代的试验行为挑战。

FDA 肿瘤中心的 @Falleh_Fallah 及其同事讨论了突破性疗法时代的平衡损失和其他试验行为挑战 - via @JCO_ASCO。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Oncology 医学-肿瘤学

CiteScore

41.20

自引率

2.20%

发文量

8215

审稿时长

2 months

期刊介绍： The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.